American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
DR
Drugs Made In America Acquisition Corp.
$10.62
+0.09%
NASDAQ: DMAA · 15-min delayed
$257.6MMarket cap
$5.9MNet income
DMAANASDAQ
2025IPO
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp is a blank check company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- $5.9M
- Total assets
- $239.9M
- Market cap
- $257.6M
Source: SEC EDGAR · updated Jun 8, 2026
FY 2025
Financial statements
Income statement
- Operating income
- -$2.8M
- Net income
- $5.9M
Balance sheet
- Total assets
- $239.9M
- Current assets
- $12.2K
- Total liabilities
- $7.3M
- Current liabilities
- $376.2K
- Shareholders’ equity
- -$7.3M
Cash flow
- Operating cash flow
- -$539.2K
- Investing cash flow
- -$231.2M
- Financing cash flow
- $231.7M
- Net cash flow
- $4.8K
Statements via Polygon.io (SEC filings)
NASDAQ: DMAA
$10.62
+0.09%
15-minute delayed · data by Polygon.io
Past year
$10.10
$10.62
52-week range
- Market cap
- $257.6M
- Shares outstanding
- 24.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 25, 2025
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $5.9M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Drugs Made In America Acquisition Corp..
Write a review
Explore
Browse all →
